SCHEMBL25848154

SCHEMBL25848154

C=C(C)C(=O)OCC(C)COc1ccc2cc(-c3ccc(CCCCC)cc3C)c(=O)oc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 5/20 0.40
MAOA P21397 1/20 0.40
NPC1 O15118 6/20 0.39
RAB9A P51151 6/20 0.39
SMN1; SMN2 Q16637 4/20 0.38
TP53 P04637 2/20 0.38
SLC10A1 Q14973 1/20 0.37
THRB P10828 1/20 0.37
KDM4E B2RXH2 4/20 0.36
ALDH1A1 P00352 4/20 0.36
HPGD P15428 4/20 0.36
GLA P06280 3/20 0.36
GAA P10253 3/20 0.36
MAPT P10636 2/20 0.36
MAPK1 P28482 2/20 0.36
HSD17B10 Q99714 2/20 0.36
PKM P14618 1/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
KLK7 P49862 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22624946 0.92 MAOB (0.40) MAOBMAOANPC1RAB9ASMN1; SMN2
SCHEMBL25848218 0.91 MAOB (0.39) MAOBMAOANPC1RAB9ASMN1; SMN2
SCHEMBL25848161 0.91 NPC1 (0.42) MAOBMAOANPC1RAB9ASMN1; SMN2
SCHEMBL25848152 0.89 THRB (0.42) MAOBMAOANPC1RAB9ASMN1; SMN2
SCHEMBL25848156 0.88 MAOB (0.37) MAOBMAOANPC1RAB9ASMN1; SMN2
SCHEMBL25848172 0.86 TP53 (0.32) MAOBMAOASMN1; SMN2TP53SLC10A1
SCHEMBL25848166 0.86 NPC1 (0.48) MAOBMAOANPC1RAB9ASMN1; SMN2
SCHEMBL25848183 0.86 MAOB (0.40) MAOBMAOANPC1RAB9ASMN1; SMN2
SCHEMBL25848237 0.84 MAOB (0.39) MAOBMAOANPC1RAB9ASMN1; SMN2
SCHEMBL25848306 0.84 MAOB (0.42) MAOBMAOANPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11702396-B2 Hydrophobic compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702396-B2 Hydrophobic compounds for optically active devices UACA, CRYZ, TRPA1 MAOB 3207/4885MAOA 2922/4885NPC1 1051/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.